Mechanisms and therapeutic potential of interactions between human amyloids and viruses

Emiel Michiels1,2, Frederic Rousseau3,4, Joost Schymkowitz5,6

  • 1VIB Center for Brain and Disease Research, Leuven, Belgium.

Insights

Amyloids, once viewed as disease-causing, can interact with viruses. These interactions can restrict or promote viral infections, with potential for new antiviral therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • Amyloid proteins are traditionally studied for their pathogenic role in diseases.
  • Emerging evidence reveals amyloids possess crucial cellular functions, including interactions with pathogens.
  • Human amyloids exhibit dual roles in viral interactions, acting as restriction factors or infectivity enhancers.

Purpose of the Study:

  • To explore the molecular mechanisms driving amyloid-virus interactions.
  • To summarize proposed hypotheses explaining how viruses and amyloids interact.
  • To highlight therapeutic potential in targeting these interactions.

Main Methods:

  • Review and synthesis of existing literature on amyloid formation and viral interactions.
  • Analysis of proposed hypotheses for amyloid-virus interplay.
  • Discussion of therapeutic strategies based on amyloid-virus specificities.

Main Results:

  • Amyloids can directly or indirectly influence viral infection processes.
  • Three non-mutually exclusive hypotheses explain amyloid-virus interactions.
  • Viruses may induce amyloid formation or be affected by existing amyloid structures.

Conclusions:

  • Amyloid-virus interactions are complex and multifaceted.
  • Understanding these interactions is key to developing novel antiviral strategies.
  • Targeting sequence-specific amyloid-virus interactions offers therapeutic promise for viral interference.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.3K
Amyloid Fibrils03:03

Amyloid Fibrils

6.1K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
83
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.5K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
325
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.3K